Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 22 02:48PM ET
334.18
Dollar change
+4.54
Percentage change
1.38
%
Index- P/E78.27 EPS (ttm)4.27 Insider Own2.15% Shs Outstand36.99M Perf Week1.00%
Market Cap12.55B Forward P/E54.01 EPS next Y6.19 Insider Trans-14.10% Shs Float36.74M Perf Month1.72%
Income163.50M PEG3.13 EPS next Q1.20 Inst Own97.61% Short Float4.48% Perf Quarter23.53%
Sales787.97M P/S15.92 EPS this Y29.64% Inst Trans-3.92% Short Ratio1.50 Perf Half Y90.95%
Book/sh20.04 P/B16.67 EPS next Y23.95% ROA13.47% Short Interest1.65M Perf Year18.23%
Cash/sh27.42 P/C12.19 EPS next 5Y25.00% ROE24.73% 52W Range157.00 - 331.58 Perf YTD75.37%
Dividend Est.- P/FCF75.51 EPS past 5Y- ROI10.72% 52W High0.78% Beta1.06
Dividend TTM- Quick Ratio12.61 Sales past 5Y142.68% Gross Margin86.99% 52W Low112.85% ATR (14)2.08
Dividend Ex-Date- Current Ratio13.81 EPS Y/Y TTM-33.55% Oper. Margin20.89% RSI (14)76.93 Volatility0.27% 0.30%
Employees1468 Debt/Eq1.03 Sales Y/Y TTM41.42% Profit Margin20.75% Recom3.00 Target Price326.05
Option/ShortYes / Yes LT Debt/Eq1.03 EPS Q/Q39.64% Payout0.00% Rel Volume1.75 Prev Close329.64
Sales Surprise5.36% EPS Surprise45.56% Sales Q/Q35.85% EarningsMay 06 AMC Avg Volume1.10M Price334.18
SMA201.22% SMA505.23% SMA20040.77% Trades Volume1,588,671 Change1.38%
Date Action Analyst Rating Change Price Target Change
Apr-05-24Downgrade Wolfe Research Outperform → Peer Perform
Mar-27-24Initiated CL King Buy $368
Sep-29-23Initiated UBS Neutral $218
Jul-10-23Upgrade Morgan Stanley Equal-Weight → Overweight $291 → $335
May-30-23Resumed Morgan Stanley Equal-Weight $291
Mar-15-23Initiated Needham Buy $240
Dec-16-22Initiated Deutsche Bank Buy $285
Dec-12-22Downgrade Wells Fargo Overweight → Equal Weight $300 → $235
Sep-06-22Downgrade Oppenheimer Perform → Underperform $165
Apr-06-22Initiated Wolfe Research Outperform $255
May-17-24 07:23AM
May-13-24 11:01AM
May-12-24 09:16AM
May-07-24 10:27AM
01:04AM
09:00PM Loading…
May-06-24 09:00PM
08:59PM
05:45PM
05:42PM
04:48PM
04:05PM
10:00AM
Apr-25-24 06:15PM
Apr-24-24 07:27AM
Apr-22-24 02:49PM
10:39AM Loading…
Apr-21-24 10:39AM
Apr-19-24 06:15PM
Apr-16-24 01:49PM
10:46AM
10:11AM
04:22AM
Apr-15-24 12:10PM
Apr-12-24 06:23AM
06:12AM
04:03AM
Apr-10-24 05:45PM
04:57AM
Apr-09-24 10:59AM
Apr-08-24 04:03PM
Apr-06-24 08:15AM
12:01AM Loading…
12:01AM
Apr-05-24 04:13PM
04:13PM
03:27PM
01:10PM
12:37PM
12:25PM
12:12PM
11:52AM
11:07AM
10:49AM
10:40AM
09:59AM
09:31AM
08:56AM
07:24AM
06:41AM
06:39AM
06:36AM
06:31AM
Apr-01-24 10:01AM
Mar-29-24 09:00AM
Mar-28-24 10:02AM
Mar-27-24 04:19PM
03:07PM
01:25PM
06:41AM
Mar-26-24 05:24PM
04:24PM
04:15PM
02:33PM
02:30PM
02:23PM
08:30AM
Mar-22-24 06:16AM
Mar-16-24 02:10AM
Mar-08-24 01:30AM
Mar-04-24 11:23AM
07:21AM
Feb-28-24 03:08AM
Feb-23-24 12:00PM
Feb-22-24 11:54PM
Feb-17-24 11:20AM
12:08AM
Feb-16-24 09:37AM
09:23AM
08:51AM
Feb-15-24 10:00PM
05:20PM
04:40PM
04:20PM
04:03PM
Feb-08-24 03:23AM
Feb-07-24 03:11AM
Feb-03-24 01:01AM
Jan-30-24 06:31AM
Jan-29-24 11:02PM
08:30AM
Jan-18-24 11:00PM
Jan-12-24 09:37AM
09:23AM
05:02AM
Jan-11-24 09:22AM
Jan-09-24 09:02AM
Jan-08-24 08:00AM
Jan-03-24 09:12AM
Dec-29-23 07:01PM
Dec-26-23 06:56PM
Dec-20-23 08:30AM
Dec-19-23 11:02AM
Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Phung TrinhVP, FinanceMay 17 '24Option Exercise6.1619,763121,78250,459May 21 05:32 PM
FRANCIS LAURADirectorMar 26 '24Option Exercise6.591,5009,8822,733Mar 27 08:04 PM
Zacharias IsaacPresident, CCOMar 26 '24Sale287.674,0001,150,68056,818Mar 27 08:02 PM
FRANCIS LAURADirectorMar 26 '24Sale300.001,500450,0003,551Mar 27 08:04 PM
WATKINS FRANK TDirectorMar 06 '24Option Exercise3.422,0006,8326,532Mar 07 09:26 PM
WATKINS FRANK TDirectorMar 06 '24Sale253.652,000507,2944,532Mar 07 09:26 PM
Phung TrinhVP, FinanceMar 06 '24Sale253.14215,31631,024Mar 06 09:10 PM
Zacharias IsaacPresident, CCOFeb 26 '24Sale260.364,0001,041,44061,372Feb 27 08:50 PM
Phung TrinhVP, FinanceFeb 22 '24Sale259.24599155,28531,031Feb 22 08:13 PM
MOLL FREDERIC HDirectorFeb 21 '24Sale257.3960,00015,443,412287,521Feb 22 08:15 PM
FRANCIS LAURADirectorFeb 16 '24Option Exercise6.591,0006,5882,233Feb 20 08:11 PM
FRANCIS LAURADirectorFeb 16 '24Sale250.001,000250,0003,551Feb 20 08:11 PM
Godshall Douglas EvanPresident & CEOFeb 15 '24Option Exercise3.4210,00034,160172,762Feb 16 08:02 PM
Godshall Douglas EvanPresident & CEOFeb 15 '24Sale231.5610,0002,315,599162,762Feb 16 08:02 PM
MOLL FREDERIC HDirectorFeb 08 '24Option Exercise0.6181,96750,000347,521Feb 09 08:07 PM
WATKINS FRANK TDirectorFeb 06 '24Option Exercise3.422,0006,8326,532Feb 07 08:16 PM
WATKINS FRANK TDirectorFeb 06 '24Sale231.762,000463,5184,532Feb 07 08:16 PM
Phung TrinhVP, FinanceFeb 06 '24Sale232.181,287298,82132,933Feb 07 08:17 PM
PUCKETT DANChief Financial OfficerFeb 05 '24Sale231.153,229746,39321,005Feb 06 08:10 PM
PUCKETT DANChief Financial OfficerFeb 01 '24Sale229.763,406782,57727,732Feb 02 08:03 PM
Zacharias IsaacPresident, CCOJan 26 '24Option Exercise6.714,00026,84067,920Jan 29 08:08 PM
Zacharias IsaacPresident, CCOJan 26 '24Sale224.694,000898,76063,920Jan 29 08:08 PM
Zacharias IsaacPresident, CCOJan 17 '24Option Exercise5.3317,92195,49863,920Jan 17 08:17 PM
Godshall Douglas EvanPresident & CEOJan 16 '24Option Exercise3.4210,00034,160151,057Jan 18 08:15 PM
Godshall Douglas EvanPresident & CEOJan 16 '24Sale217.5910,0002,175,858141,057Jan 18 08:15 PM
WATKINS FRANK TDirectorJan 08 '24Option Exercise3.422,0006,8326,532Jan 10 08:10 PM
WATKINS FRANK TDirectorJan 08 '24Sale198.992,000397,9754,532Jan 10 08:10 PM
Godshall Douglas EvanPresident & CEOJan 05 '24Option Exercise3.4210,00034,160151,057Jan 08 08:18 PM
Godshall Douglas EvanPresident & CEOJan 05 '24Sale200.0510,0002,000,500141,057Jan 08 08:18 PM
Zacharias IsaacPresident, CCODec 26 '23Option Exercise6.713,45823,20345,606Dec 28 08:35 PM
Zacharias IsaacPresident, CCODec 26 '23Sale192.504,000770,00041,606Dec 28 08:35 PM
Godshall Douglas EvanPresident & CEODec 15 '23Option Exercise3.425,00017,080146,057Dec 18 08:09 PM
Godshall Douglas EvanPresident & CEODec 15 '23Sale187.805,000938,975141,057Dec 18 08:09 PM
PUCKETT DANChief Financial OfficerDec 08 '23Sale173.8820034,77628,784Dec 11 08:03 PM
Phung TrinhVP, FinanceDec 07 '23Sale171.6320334,84129,037Dec 08 08:21 PM
Zacharias IsaacPresident, CCONov 27 '23Option Exercise6.713,77725,34447,868Nov 28 08:02 PM
Zacharias IsaacPresident, CCONov 27 '23Sale173.584,000694,32043,868Nov 28 08:02 PM
WATKINS FRANK TDirectorNov 20 '23Option Exercise3.423,00010,2484,532Nov 21 08:15 PM
WATKINS FRANK TDirectorNov 20 '23Sale173.353,000520,0471,532Nov 21 08:15 PM
Godshall Douglas EvanPresident & CEONov 15 '23Option Exercise3.425,00017,080141,057Nov 17 08:00 PM
Godshall Douglas EvanPresident & CEONov 15 '23Sale174.085,000870,407136,057Nov 17 08:00 PM
Zacharias IsaacPresident, CCOOct 26 '23Option Exercise6.714112,75848,316Oct 30 08:02 PM
Zacharias IsaacPresident, CCOOct 26 '23Sale210.254,000841,00044,316Oct 30 08:02 PM
WATKINS FRANK TDirectorOct 20 '23Option Exercise3.423,00010,2484,532Oct 23 08:01 PM
WATKINS FRANK TDirectorOct 20 '23Sale202.703,000608,0861,532Oct 23 08:01 PM
Godshall Douglas EvanPresident & CEOOct 16 '23Option Exercise3.4210,00034,160151,649Oct 17 08:10 PM
Godshall Douglas EvanPresident & CEOOct 16 '23Sale200.7810,0002,007,821141,649Oct 17 08:10 PM
Zacharias IsaacPresident, CCOSep 26 '23Sale192.124,000768,48047,905Sep 27 07:02 PM
WATKINS FRANK TDirectorSep 20 '23Option Exercise3.423,00010,2484,532Sep 21 08:10 PM
WATKINS FRANK TDirectorSep 20 '23Sale209.233,000627,6901,532Sep 21 08:10 PM
Godshall Douglas EvanPresident & CEOSep 15 '23Option Exercise3.4210,00034,160151,649Sep 19 08:10 PM
Godshall Douglas EvanPresident & CEOSep 15 '23Sale212.8610,0002,128,615141,649Sep 19 08:10 PM
Phung TrinhVP, FinanceAug 29 '23Option Exercise3.425,00017,08025,986Aug 31 08:30 PM
Zacharias IsaacPresident, CCOAug 25 '23Sale204.984,000819,92052,446Aug 29 08:16 PM
Godshall Douglas EvanPresident & CEOAug 24 '23Option Exercise3.4210,00034,160151,649Aug 25 08:09 PM
Godshall Douglas EvanPresident & CEOAug 24 '23Sale214.6210,0002,146,171141,649Aug 25 08:09 PM
FRANCIS LAURADirectorAug 22 '23Sale220.97497109,8223,054Aug 23 08:07 PM
WATKINS FRANK TDirectorAug 21 '23Option Exercise3.423,00010,2484,532Aug 22 08:14 PM
WATKINS FRANK TDirectorAug 21 '23Sale219.293,000657,8701,532Aug 22 08:14 PM
Toyloy SaraDirectorAug 15 '23Sale223.6410022,3643,673Aug 16 08:05 PM
Zacharias IsaacPresident, CCOJul 26 '23Sale268.064,0001,072,24056,678Jul 27 08:09 PM
WATKINS FRANK TDirectorJul 20 '23Option Exercise3.423,00010,2484,532Jul 21 07:52 PM
WATKINS FRANK TDirectorJul 20 '23Sale267.173,000801,5071,532Jul 21 07:52 PM
Papiernik AntoineDirectorJul 05 '23Option Exercise17.0017,381295,47722,662Jul 06 08:40 PM
Zacharias IsaacPresident, CCOJun 26 '23Sale291.844,0001,167,36060,678Jun 26 09:11 PM
Phung TrinhVP, FinanceJun 23 '23Sale295.916218,34621,101Jun 26 09:09 PM
WATKINS FRANK TDirectorJun 20 '23Sale287.523,000862,5731,532Jun 21 08:11 PM
Zacharias IsaacPresident, CCOMay 26 '23Sale277.534,0001,110,12065,223May 30 08:00 PM
Last Close
May 22 02:45PM ET
0.9001
Dollar change
+0.0127
Percentage change
1.43
%
Index- P/E- EPS (ttm)-0.59 Insider Own34.37% Shs Outstand56.84M Perf Week3.46%
Market Cap64.82M Forward P/E- EPS next Y-0.51 Insider Trans-0.02% Shs Float47.26M Perf Month9.90%
Income-41.93M PEG- EPS next Q-0.14 Inst Own11.20% Short Float2.70% Perf Quarter-12.61%
Sales11.69M P/S5.54 EPS this Y14.25% Inst Trans-5.16% Short Ratio13.84 Perf Half Y-23.07%
Book/sh1.05 P/B0.86 EPS next Y3.87% ROA-40.40% Short Interest1.28M Perf Year-33.82%
Cash/sh0.88 P/C1.03 EPS next 5Y- ROE-44.51% 52W Range0.76 - 3.28 Perf YTD-19.63%
Dividend Est.- P/FCF- EPS past 5Y- ROI-55.43% 52W High-72.56% Beta0.86
Dividend TTM- Quick Ratio8.26 Sales past 5Y275.41% Gross Margin42.39% 52W Low18.23% ATR (14)0.09
Dividend Ex-Date- Current Ratio9.09 EPS Y/Y TTM32.85% Oper. Margin-391.12% RSI (14)54.62 Volatility12.48% 9.49%
Employees131 Debt/Eq0.00 Sales Y/Y TTM47.25% Profit Margin-358.59% Recom2.33 Target Price1.27
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q20.22% Payout- Rel Volume4.18 Prev Close0.89
Sales Surprise8.08% EPS Surprise4.57% Sales Q/Q25.05% EarningsMay 13 AMC Avg Volume92.16K Price0.90
SMA208.48% SMA50-4.14% SMA200-33.09% Trades Volume317,926 Change1.43%
Date Action Analyst Rating Change Price Target Change
Aug-11-22Downgrade Wells Fargo Overweight → Equal Weight $8 → $2.40
May-31-22Initiated Evercore ISI Outperform $7
Apr-14-22Initiated Wells Fargo Overweight $8
Today 09:00AM
May-14-24 03:04AM
May-13-24 08:53PM
05:15PM
04:05PM
09:00AM Loading…
May-10-24 09:00AM
May-06-24 10:00AM
Apr-29-24 04:05PM
Apr-25-24 09:35AM
Apr-23-24 09:00AM
Apr-17-24 09:00AM
Mar-21-24 08:53PM
05:25PM
04:05PM
Mar-12-24 09:00AM
04:30PM Loading…
Mar-07-24 04:30PM
Feb-28-24 04:30PM
Feb-21-24 09:00AM
Feb-01-24 08:00AM
Jan-09-24 09:00AM
Nov-29-23 07:07AM
Nov-20-23 09:00AM
Nov-16-23 09:00AM
Nov-12-23 10:10AM
Nov-09-23 04:05PM
Nov-02-23 09:15AM
Oct-19-23 04:05PM
Oct-10-23 04:05PM
Oct-09-23 09:00AM
Sep-07-23 04:05PM
04:05PM Loading…
Aug-14-23 04:05PM
Aug-09-23 09:00AM
Jul-24-23 04:05PM
Jul-18-23 04:05PM
Jul-11-23 09:00AM
Jun-08-23 09:00AM
May-18-23 09:00AM
May-11-23 04:05PM
Apr-20-23 04:05PM
Mar-21-23 04:05PM
Mar-06-23 08:55AM
Feb-28-23 08:55AM
Feb-21-23 08:55AM
Feb-13-23 08:55AM
Feb-09-23 04:10PM
Feb-08-23 04:05PM
Feb-06-23 06:31PM
Nov-22-22 04:05PM
Nov-10-22 04:05PM
Oct-27-22 04:10PM
Oct-06-22 09:00AM
Sep-07-22 08:30AM
Aug-24-22 04:10PM
Aug-15-22 06:11AM
Aug-10-22 04:05PM
Jul-20-22 04:15PM
Jul-14-22 09:00AM
Jun-29-22 04:05PM
Jun-18-22 08:10AM
08:07AM
Jun-14-22 04:10AM
May-25-22 04:10PM
May-11-22 04:05PM
May-03-22 12:15PM
10:31AM
Apr-20-22 04:05PM
Mar-31-22 06:18PM
Mar-23-22 04:05PM
Mar-03-22 09:00AM
Mar-01-22 04:10PM
Feb-16-22 08:00AM
Feb-08-22 08:00AM
Feb-07-22 05:38PM
Jan-19-22 08:00AM
Jan-10-22 07:30AM
Jan-04-22 08:30AM
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEISSEYRE THOMASChief Operating OfficerMay 16 '24Sale0.882,7532,42393,773May 16 05:33 PM
TEISSEYRE THOMASChief Operating OfficerFeb 16 '24Sale1.113,2303,58596,526Feb 16 04:06 PM
TEISSEYRE THOMASChief Operating OfficerNov 16 '23Sale1.262,6553,34599,756Nov 17 07:34 PM
TEISSEYRE THOMASChief Operating OfficerAug 16 '23Sale2.262,7856,294102,411Aug 17 04:45 PM
Siddiqui KhanCMO and Chief Strategy OfficerAug 16 '23Sale2.261,7293,90876,981Aug 17 04:44 PM